Endo, Inc. (NDOI)
OTCMKTS · Delayed Price · Currency is USD
23.76
+0.01 (0.04%)
Jul 28, 2025, 4:00 PM EDT
Endo, Inc. Employees
Endo, Inc. had 3,116 employees as of December 31, 2024. The number of employees increased by 185 or 6.31% compared to the previous year.
Employees
3,116
Change (1Y)
185
Growth (1Y)
6.31%
Revenue / Employee
$556,311
Profits / Employee
$1,819,016
Market Cap
1.81B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3,116 | 185 | 6.31% |
Dec 31, 2023 | 2,931 | 70 | 2.45% |
Dec 31, 2022 | 2,861 | -242 | -7.80% |
Dec 31, 2021 | 3,103 | -294 | -8.65% |
Dec 31, 2020 | 3,397 | 225 | 7.09% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Tian'an Technology Group | 8 |
Elite Pharmaceuticals | 68 |
Glass House Brands | 374 |
Northwest Biotherapeutics | 25 |
CytoDyn | 9 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
Endo, Inc. News
- 5 days ago - Endo Presents Plantar Fibromatosis and Plantar Fasciitis Data at the American Podiatric Medical Association Annual Meeting - PRNewsWire
- 8 days ago - Endo to Report Second Quarter 2025 Financial Results on August 6, 2025 - PRNewsWire
- 12 days ago - Mallinckrodt Receives Necessary Ruling from Irish High Court to Combine with Endo, Inc. - PRNewsWire
- 15 days ago - Aspect Biosystems Presents New Preclinical Data on Adrenal Bioprinted Tissue Therapeutics at ENDO 2025 - Business Wire
- 15 days ago - Marea Therapeutics Presents Preclinical Data on Novel Growth Hormone Receptor Antagonist Antibody, MAR002, for the Treatment of Acromegaly at ENDO 2025 - Business Wire
- 15 days ago - OMass Therapeutics Presents Positive Preclinical Data For its Best-in-class MC2 Program at ENDO 2025 - GlobeNewsWire
- 5 weeks ago - Marea Therapeutics Announces Oral Presentation Related to Acromegaly Program at ENDO 2025 - Business Wire
- 6 weeks ago - Endo Completes International Pharmaceuticals Business Divestiture - PRNewsWire